SCSU Communication Sciences and Disorders faculty launched the POUNCE program in 2022 to address long waitlists worsened by COVID-19 while giving students hands-on experience.
Community Wellness Partner’s 23rd Annual Parkinson’s Awareness Walk took place Saturday in New Hartford's Sherrill Brook Park ...
Known primarily as a movement disorder, Parkinson’s also affects speech, swallowing, and the ability to perform daily ...
A tiny brain blip during silent speech revealed the shocking truth: Your brain plans words by imagining sounds, not movements ...
AbbVie, which last year won FDA approval of its Vyalev subcutaneous 24-hour infusion therapy for Parkinson's, said a green light for tavapadon would bolster its position in the disease by providing ...
Huntington’s disease has been successfully treated for the first time using a gene therapy, which may be available in the US ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
Bayer announced today progress for two potential therapies against Parkinson’s disease (PD). A first participant received randomized treatment in the pivotal Phase III clinical trial, exPDite-2, of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback